In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile

Leukemia, Published online: 28 December 2023; doi:10.1038/s41375-023-02122-5In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile

Source: Leukemia - December 28, 2023 Category: Hematology Authors: Ho-Jae Han Jaeyoon John Kim Danielle Pyne Anthea Travas Amirthagowri Ambalavanan Shinya Kimura Michael W. Deininger Jong-Won Kim Dennis Dong Hwan Kim Source Type: research